van Mourik Martijn S, van der Velde Nathalie, Mannarino Giulio, Thibodeau Marie-Pierre, Masson Jean-Bernard, Santoro Gennaro, Baan Jan, Jansen Sofie, Kurucova Jana, Thoenes Martin, Deutsch Cornelia, Schoenenberger Andreas W, Ungar Andrea, Bramlage Peter, Vis M Marije
Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
J Geriatr Cardiol. 2019 Jun;16(6):468-477. doi: 10.11909/j.issn.1671-5411.2019.06.001.
In a three-month report from the CGA-TAVI registry, we found the Multidimensional Prognostic Index (MPI) and Short Physical Performance Battery (SPPB) to be of value for predicting short-term outcomes in elderly patients undergoing transcatheter aortic valve implantation (TAVI). In the present analysis, we examined the association of these tools with outcomes up to one year post-TAVI.
CGA-TAVI is an international, observational registry of geriatric patients undergoing TAVI. Patients were assessed using the MPI and SPPB. Efficacy of baseline values and any postoperative change for predicting outcome were established using logistic regression. Kaplan-Meier analysis was carried out for each comprehensive geriatric assessment tool, with survival stratified by risk category.
One year after TAVI, 14.1% of patients deceased, while 17.4% met the combined endpoint of death and/or non-fatal stroke, and 37.7% the combined endpoint of death and/or hospitalisation and/or non-fatal stroke. A high-risk MPI score was associated with an increased risk of all-cause mortality (aOR = 36.13, 95% CI: 2.77-470.78, = 0.006) and death and/or non-fatal stroke (aOR = 10.10, 95% CI: 1.48-68.75, = 0.018). No significant associations were found between a high-risk SPPB score and mortality or two main combined endpoints. In contrast to a worsening SPPB, an aggravating MPI score at three months post-TAVI was associated with an increased risk of death and/or non-fatal stoke at one year (aOR = 95.16, 95% CI: 3.41-2657.01).
The MPI showed value for predicting the likelihood of death and a combination of death and/or non-fatal stroke by one year after TAVI in elderly patients.
在CGA-TAVI注册研究的一份三个月报告中,我们发现多维预后指数(MPI)和简短体能状况量表(SPPB)对预测接受经导管主动脉瓣植入术(TAVI)的老年患者的短期预后具有价值。在本分析中,我们研究了这些工具与TAVI术后长达一年的预后之间的关联。
CGA-TAVI是一项针对接受TAVI的老年患者的国际观察性注册研究。使用MPI和SPPB对患者进行评估。通过逻辑回归确定基线值和术后任何变化对预测预后的有效性。对每种综合老年评估工具进行Kaplan-Meier分析,生存情况按风险类别分层。
TAVI术后一年,14.1%的患者死亡,17.4%的患者达到死亡和/或非致命性卒中的联合终点,37.7%的患者达到死亡和/或住院和/或非致命性卒中的联合终点。高风险MPI评分与全因死亡率增加(调整后比值比[aOR]=36.13,95%置信区间[CI]:2.77-470.78,P=0.006)以及死亡和/或非致命性卒中(aOR=10.10,95%CI:1.48-68.75,P=0.018)相关。未发现高风险SPPB评分与死亡率或两个主要联合终点之间存在显著关联。与SPPB恶化相反,TAVI术后三个月时MPI评分恶化与一年时死亡和/或非致命性卒中风险增加相关(aOR=95.16,95%CI:3.41-2657.01)。
MPI对于预测老年患者TAVI术后一年的死亡可能性以及死亡和/或非致命性卒中的组合具有价值。